Warburg effect regulated by amphiregulin in the development of colorectal cancer

AMP-activated protein kinase: A target for old drugs against diabetes and cancer

(2013) Gian Luigi Russo et al.   BIOCHEMICAL PHARMACOLOGY

Altered energy metabolism in cancer

(2013) Yi Zhang et al.   CANCER BIOLOGY & THERAPY

Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect

(2013) K. K. Velpula et al.   CANCER RESEARCH

Tumor glycolysis as a target for cancer therapy: progress and prospects

(2013) Shanmugasundaram Ganapathy-Kanniappan et al.   Molecular Cancer

ChREBP Mediates Glucose-Stimulated Pancreatic  -Cell Proliferation

(2012) M. R. Metukuri et al.   DIABETES

Burden of Gastrointestinal Disease in the United States: 2012 Update

(2012) Anne F. Peery et al.   GASTROENTEROLOGY

ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect

(2012) Weiwei Yang et al.   NATURE CELL BIOLOGY

Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis

(2012) D. Soranna et al.   ONCOLOGIST

Glucose sensing by ChREBP/MondoA–Mlx transcription factors

(2012) Essi Havula et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Timing and intensity of recreational physical activity and the risk of subsite-specific colorectal cancer

(2011) Terry Boyle et al.   CANCER CAUSES & CONTROL

Insulin receptor and cancer

(2011) A. Belfiore et al.   ENDOCRINE-RELATED CANCER

Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer

(2010) Fusanori Yotsumoto et al.   CANCER SCIENCE

Hypoxia-inducible factor independent down-regulation of thioredoxin-interacting protein in hypoxia

(2010) Tin Fan Chai et al.   FEBS LETTERS

Linking diabetes and cancer: a consensus on complexity

(2010) Andrew Renehan et al.   LANCET

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol

(2010) Ming Zhou et al.   Molecular Cancer

Diabetes and cancer

(2009) Paolo Vigneri et al.   ENDOCRINE-RELATED CANCER

Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy

(2009) BS Dwarakanath et al.   Future Oncology

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Glucose sensing by MondoA:Mlx complexes: A role for hexokinases and direct regulation of thioredoxin-interacting protein expression

(2008) C. A. Stoltzman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Validation of HB-EGF and amphiregulin as targets for human cancer therapy

(2007) Fusanori Yotsumoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS